La mama en la mujer transgénero. Revisión sistemática
Palabras clave:
Personas Transgénero, Mujeres, MamaResumen
Revisar la información sobre la mama en la mujer transgénero Métodos: Se realizó una búsqueda de artículos registrados en la base de datos de Pubmed y Lilacs con los términos “Breast and transgender women” (Pubmed) y “mama y mujeres transgénero” (Lilacs) sin uso de filtros, realizada en julio de 2021, buscando artículos con información primaria. Resultados: La búsqueda en las bases de datos encontró 115 artículos de los cuales, luego de la selección y lectura completa, se extrajeron 33 para su inclusión en esta revisión. Se agrupan los artículos en cambios mamarios con la terapia para feminización, lactancia, reportes de patología mamaria benigna, mamoplastia de aumento, pesquisa, cáncer de mama, linfoma anaplásico de células grandes asociado a implantes mamarios y otros. Conclusiones: El desarrollo mamario es muy importante para la mujer transgénero y en algunas también lo es la lactancia. En su consecución se someten a tratamientos médicos y con frecuencia a procedimientos quirúrgicos. Sin embargo, esto también se acompaña de modificaciones en los factores de riesgo y en la posibilidad de desarrollar tumores benignos y malignos. Se presenta información primaria sobre estos temas.
Descargas
Citas
American College of Obstetricians and Gynecologists’ Committee on Gynecologic Practice; American College of Obstetricians and Gynecologists’ Committee on Health Care for Underserved Women. Health Care for Transgender and Gender Diverse Individuals: ACOG Committee Opinion, Number 823. Obstet Gynecol. 2021;137(3):e75-e88. DOI: 10.1097/AOG.0000000000004294.
Macias H, Hinck L. Mammary gland development. Wiley Interdiscip Rev Dev Biol. 2012;1(4):533-557. DOI: 10.1002/wdev.35.
Wamboldt R, Shuster S, Sidhu BS. Lactation Induction in a Transgender Woman Wanting to Breastfeed: Case Report. J Clin Endocrinol Metab. 2021;106(5):e2047-e2052. DOI: 10.1210/clinem/dgaa976.
Sonnenblick EB, Shah AD, Goldstein Z, Reisman T. Breast Imaging of Transgender Individuals: A Review. Curr Radiol Rep. 2018;6(1):1. DOI: 10.1007/s40134-018-0260-1.
van de Grift TC, van Gelder ZJ, Mullender MG, Steensma TD, de Vries ALC, Bouman MB. Timing of Puberty Suppression and Surgical Options for Transgender Youth. Pediatrics. 2020;146(5):e20193653. DOI: 10.1542/peds.2019-3653.
Masumori N, Baba T, Abe T, Niwa K. What is the most anticipated change induced by treatment using gender-affirming hormones in individuals with gender incongruence? Int J Urol. 2021;28(5):526-529. DOI: 10.1111/iju.14499.
de Blok CJM, Dijkman BAM, Wiepjes CM, Staphorsius AS, Timmermans FW, Smit JM, et al. Sustained Breast Development and Breast Anthropometric Changes in 3 Years of Gender-Affirming Hormone Treatment. J Clin Endocrinol Metab. 2021;106(2):e782-e790. DOI: 10.1210/clinem/dgaa841.
Alcon A, Wang E, Oliver-Allen H, Srinivasa D, Kim EA. The Breast Response to Estrogenic Stimulation in Transwomen Classification: Evaluation of Breast Response to Estrogenic Stimulation in Transwomen. Ann Plast Surg. 2021;87(4):402-408. DOI: 10.1097/SAP.0000000000002729.
Trautner E, McCool-Myers M, Joyner AB. Knowledge and practice of induction of lactation in trans women among professionals working in trans health. Int Breastfeed J. 2020;15(1):63. DOI: 10.1186/s13006-020-00308-6.
Reisman T, Goldstein Z. Case Report: Induced Lactation in a Transgender Woman. Transgend Health. 2018;3(1):24-26. DOI: 10.1089/trgh.2017.0044.
de Blok CJ, Dijkman BA, Wiepjes CM, Konings IR, Dreijerink KM, Barbé E, et al. Frequency and outcomes of benign breast biopsies in trans women: A nationwide cohort study. Breast. 2021;57:118-122. DOI: 10.1016/j.breast.2021.03.007.
Komforti MK, Fineberg S, Koenigsberg T, Harmon BE. Unilateral pseudoangiomatous stromal hyperplasia in a transgender (male to female) woman on estrogen therapy. Breast J. 2020; 26 (2): 265-266. DOI: 10.1111/tbj.13547
de Faria LL, Brasil ST, Endo E, Chala L, Shimizu C, de Barros N. Breast fibroadenoma in transgender woman. Breast J. 2020;26(2):293-294. DOI: 10.1111/tbj.13548.
O’Bryan J, Wolf-Gould C, Matsuo Y. Mammary Myofibroblastoma in a Transgender Patient on Feminizing Hormones: Literature Review and Case Report. Transgend Health. 2018;3(1):1-9. DOI: 10.1089/trgh.2017.0026.
Sam KQ, Severs FJ, Ebuoma LO, Chandandeep NS, Sedgwick EL. Granulomatous Mastitis in a Transgender Patient. J Radiol Case Rep. 2017;11(2):16-22. DOI: 10.3941/jrcr.v11i2.2934.
Richards SM, Pine-Twaddell ED, Ioffe OB, Bellavance EC. A Case of Benign Phyllodes Tumor in a Transgender Woman Receiving Cross-Sex Hormones. Int J Surg Pathol. 2018;26(4):356-359. DOI: 10.1177/1066896917743011.
Cuccolo NG, Kang CO, Boskey ER, Ibrahim AMS, Blankensteijn LL, Taghinia A, et al. Epidemiologic Characteristics and Postoperative Complications following Augmentation Mammaplasty: Comparison of Transgender and Cisgender Females. Plast Reconstr Surg Glob Open. 2019;7(10):e2461. DOI: 10.1097/GOX.0000000000002461.
Gabrick KS, Chouiari F, Park KE, Allam O, Mozaffari MA, Persing JA, et al. A comparison of perioperative safety for breast augmentation in cis- vs. trans patients. Ann Transl Med. 2021;9(7):601. DOI: 10.21037/atm-20-3355.
Miller TJ, Wilson SC, Massie JP, Morrison SD, Satterwhite T. Breast augmentation in male-to-female transgender patients: Technical considerations and outcomes. JPRAS Open. 2019;21:63-74. DOI: 10.1016/j.jpra.2019.03.003.
Fakin RM, Zimmermann S, Kaye K, Lunger L, Weinforth G, Giovanoli P. Long-Term Outcomes in Breast Augmentation in Trans-Women: A 20-Year Experience. Aesthet Surg J. 2019;39(4):381-390. DOI: 10.1093/asj/sjy143.
Sijben I, Timmermans FW, Lapid O, Bouman MB, van der Sluis WB. Long-term Follow-up and Trends in Breast Augmentation in 527 Transgender Women and Nonbinary Individuals: A 30-year experience in Amsterdam. J Plast Reconstr Aesthet Surg. 2021;74(11):3158-3167. DOI: 10.1016/j.bjps.2021.03.107.
Coon D, Lee E, Fischer B, Darrach H, Landford WN. Breast Augmentation in the Transfemale Patient: Comprehensive Principles for Planning and Obtaining Ideal Results. Plast Reconstr Surg. 2020;145(6):1343-1353. DOI: 10.1097/PRS.0000000000006819.
Mehra G, Kaufman-Goldberg T, Meshulam-Derazon S, Boskey ER, Ganor O. Use of the Subfascial Plane for Gender-affirming Breast Augmentation: A Case Series. Plast Reconstr Surg Glob Open. 2021;9(1):e3362. DOI: 10.1097/GOX.0000000000003362.
Motmans J, Meier P, Ponnet K, T’Sjoen G. Female and male transgender quality of life: socioeconomic and medical differences. J Sex Med. 2012;9(3):743-50. DOI: 10.1111/j.1743-6109.2011.02569.x.
Margulies IG, Xu H, Kozato A, Facque A, Taub PJ. Breast Reduction Following Hormonal Therapy in a Transgender Female Patient. Ann Plast Surg. 2019;83(4):401-403. DOI: 10.1097/SAP.0000000000001855.
de Blok CJM, Wiepjes CM, Nota NM, van Engelen K, Adank MA, Dreijerink KMA, et al. Breast cancer risk in transgender people receiving hormone treatment: nationwide cohort study in the Netherlands. BMJ. 2019;365:l1652. DOI: 10.1136/bmj.l1652.
Weyers S, Villeirs G, Vanherreweghe E, Verstraelen H, Monstrey S, Van den Broecke R, et al. Mammography and breast sonography in transsexual women. Eur J Radiol. 2010;74(3):508-13. DOI: 10.1016/j.ejrad.2009.03.018.
Donati A, Nagelberg A. Screening mamario en pacientes transgénero bajo tratamiento hormonal cruzado (THC). Situación actual y controversias. Rev. argent. mastol. [Internet]. 2019 [consultado 30 de julio de 2021];38(137):116-132. Disponible en: https://www.revistasamas.org.ar/revistas/2019_v38_n137/10.pdf
Tabaac AR, Sutter ME, Wall CSJ, Baker KE. Gender Identity Disparities in Cancer Screening Behaviors. Am J Prev Med. 2018;54(3):385-393. DOI: 10.1016/j.amepre.2017.11.009.
Bazzi AR, Whorms DS, King DS, Potter J. Adherence to Mammography Screening Guidelines Among Transgender Persons and Sexual Minority Women. Am J Public Health. 2015;105(11):2356-2358. DOI: 10.2105/AJPH.2015.302851.
Colebunders B, T’Sjoen G, Weyers S, Monstrey S. Hormonal and surgical treatment in trans-women with BRCA1 mutations: a controversial topic. J Sex Med. 2014;11(10):2496-2499. DOI: 10.1111/jsm.12628.
Stewart T, Lee YA, Damiano EA. Do Transgender and Gender Diverse Individuals Receive Adequate Gynecologic Care? An Analysis of a Rural Academic Center. Transgend Health. 2020;5(1):50-58. DOI: 10.1089/trgh.2019.0037.
Lienhoop T, Smetko M, Green L. Breast cancer in transgender women: A case report. Clin Imaging. 2020;68:20-23. DOI: 10.1016/j.clinimag.2020.05.006.
de Boer M, van der Sluis WB, de Boer JP, Overbeek LIH, van Leeuwen FE, Rakhorst HA, et al. Breast Implant-Associated Anaplastic Large-Cell Lymphoma in a Transgender Woman. Aesthet Surg J. 2017;37(8):NP83-NP87. DOI: 10.1093/asj/sjx098.
Patzelt M, Zarubova L, Klener P, Barta J, Benkova K, Brandejsova A, et al. Anaplastic Large-Cell Lymphoma Associated with Breast Implants: A Case Report of a Transgender Female. Aesthetic Plast Surg. 2018;42(2):451-455. DOI: 10.1007/s00266-017-1012-y.
Unger CA. Care of the transgender patient: a survey of gynecologists’ current knowledge and practice. J Womens Health (Larchmt). 2015;24(2):114-118. DOI: 10.1089/jwh.2014.4918.
Berro T, Zayhowski K, Field T, Channaoui N, Sotelo J. Genetic counselors’ comfort and knowledge of cancer risk assessment for transgender patients. J Genet Couns. 2020;29(3):342-351. DOI: 10.1002/jgc4.1172.
Maycock LB, Kennedy HP. Breast care in the transgender individual. J Midwifery Womens Health. 2014;59(1):74-81. DOI: 10.1111/jmwh.12066.
García-Acosta JM, San Juan-Valdivia RM, Fernández-Martínez AD, Lorenzo-Rocha ND, Castro-Peraza ME. Trans* Pregnancy and Lactation: A Literature Review from a Nursing Perspective. Int J Environ Res Public Health. 2019;17(1):44. DOI: 10.3390/ijerph17010044.
